TSH suppression therapy for active surveillance in thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial is for patients with a small thyroid cancer (1 cm or less) that is not aggressive. It tests whether taking thyroid hormone to keep TSH low is necessary during active surveillance (watching the cancer closely instead of removing it right away).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thyroid nodule 1 cm or smaller that is likely or confirmed to be papillary thyroid cancer
- Your cancer has not spread to lymph nodes, distant parts of the body, or invaded nearby structures
- Your cancer is not a high-risk type (like diffuse sclerosing, columnar cell, or solid subtype)
- You are not pregnant and can have children
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study is testing whether it is safe to simply monitor (watch closely) a small thyroid nodule that has a certain biopsy result (Bethesda IV) instead of removing it right away. You would not receive a treatment, but would have regular checkups and ultrasounds to see if the nodule changes.
This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.
This study helps patients with small, low-risk thyroid cancer choose between active surveillance and immediate surgery. It focuses on shared decision-making to match the treatment to your values and preferences.
This study looks at how doctors talk with patients who have a thyroid nodule that may need a biopsy. It aims to improve communication and help patients feel more involved in their care.
This trial is for people with low-risk papillary thyroid cancer. It compares two surgical approaches: one that removes just the thyroid gland, and another that also removes some lymph nodes in the center of the neck as a preventive measure. The goal is to see if removing these lymph nodes helps prevent the cancer from coming back.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.